Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Initial Public Offering (NasdaqNM: OMER) in October […]
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Initial Public Offering (NasdaqNM: OMER) in October […]